Mode
Text Size
Log in / Sign up
N/A N=136 Treatment

Veterans Affairs Lowering Readmission in Heart Failure

Heart Failure

Enrolled (actual)
136
Serious AEs
11.0%
Results posted
Oct 2015
Primary outcome: Primary: General Quality of Life From the Standardized Physical Component Score — 31.6; 35.5 units on a scale — p=0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Comprehensive quality improvement program (QIP) (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Jul 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
General Quality of Life From the Standardized Physical Component Score
31.6; 35.5 0.05
PRIMARY
Heart Failure Specific Quality of Life
42.5; 38.0 0.26
SECONDARY
Standardized Mental Component Score
48.8; 53.2 .56
SECONDARY
Physical Functioning
37.5; 41.4 0.22
SECONDARY
Role Physical
50.0; 53.1 0.05
SECONDARY
Pain Index
51.0; 61.5 0.34
SECONDARY
General Health
41.0; 57.0 0.008 sig
SECONDARY
Vitality
45.0; 50.0 0.30
SECONDARY
Social Functioning
62.0; 75.0 0.15
SECONDARY
Role Emotional
66.7; 75.0 0.55
SECONDARY
Mental Health
74.0; 80.0 0.56
SECONDARY
Physical Subscale of Heart Failure Specific Quality of Life
21.5; 19.0 0.15
SECONDARY
Emotional Subscale of Heart Failure Specific Quality of Life
7.0; 6.0 0.36

Summary

Heart failure (HF) greatly increases mortality and lowers quality of life (QOL). HF is the most common indication for readmission in older adults and the most frequent reason for 30-day readmission. Medications and restriction of dietary sodium constitute crucial therapy to lower HF recurrence. However, adherence to medications and dietary recommendations is low in HF patients. Nonadherence is often due to an interaction among the environment, the patient and providers. In the VALOR in Heart Failure Study, we will assess a novel quality improvement program (QIP) to improve HF care using a pretest-posttest design. This interdisciplinary theory-based prospective experimental study will target improving HF treatment using patient-based behavioral and checklist intervention, as well as provider and system-targeted checklists and treatment defaults (posttest or intervention phase); this will be compared to current best practice (CBP) evaluated in the pretest (pretest or pre-intervention) phase. It is hypothesized that the QIP, which intervenes on patient, provider and system levels, will improve QOL and lower HF recurrence compared to CBP.

Eligibility Criteria

Inclusion Criteria

  • All patients admitted with either systolic or diastolic HF will be identified through ongoing daily prospective manual search of admission records in VA NYHHS
  • Men and women ( 21 years) being discharged after a HF admission will be eligible
  • They must have an available phone

Exclusion Criteria

  • Patients with poor short-term survival (< 3 months)
  • recent major surgery (< 1 month)
  • planned discharge to a long-term-care facility
  • severe dementia or other serious psychiatric illness
  • temporarily in the area
  • those unable to provide consent, refusal to participate
  • logistic or discretionary reasons (including participation in another study) will be excluded
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01144182). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search